Victoria Vakiener - Jan 10, 2023 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/Victoria Vakiener
Stock symbol
ARWR
Transactions as of
Jan 10, 2023
Transactions value $
$0
Form type
4
Date filed
1/11/2023, 07:35 PM
Previous filing
Jun 24, 2022
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Disposed to Issuer $0 -1.76K -10.27% $0.00 15.4K Jan 10, 2023 Direct F1
transaction ARWR Common Stock Award $0 +7.87K +51.03% $0.00 23.3K Jan 10, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARWR Common Stock Award $0 +4.59K $0.00 4.59K Jan 10, 2023 Common Stock 4.59K $33.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Correction to previously granted award from 17,181 to 15,417.
F2 Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
F3 Includes a total of 15,417 shares underlying restricted stock units, which vest over three years.
F4 Represents options, which will vest in one installment on the first anniversary of the grant date.